1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Active Pharmaceutical Ingredient Revenue
1.4 Market Analysis by Type
1.4.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Synthetic API
1.4.3 Biotech API
1.4.4 Other
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredient Market Share by Application: 2021-2026
1.5.2 Chemical
1.5.3 Deodorant
1.5.4 Dailylife
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Active Pharmaceutical Ingredient Market
1.8.1 Global Active Pharmaceutical Ingredient Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredient Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Active Pharmaceutical Ingredient Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Active Pharmaceutical Ingredient Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Active Pharmaceutical Ingredient Sales Volume Market Share by Region (2015-2020)
3.2 Global Active Pharmaceutical Ingredient Sales Revenue Market Share by Region (2015-2020)
3.3 North America Active Pharmaceutical Ingredient Sales Volume
3.3.1 North America Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.3.2 North America Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Active Pharmaceutical Ingredient Sales Volume
3.4.1 East Asia Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.5.1 Europe Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.6.1 South Asia Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.7.1 Southeast Asia Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.8.1 Middle East Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.9.1 Africa Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.10.1 Oceania Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.11.1 South America Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.11.2 South America Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Active Pharmaceutical Ingredient Sales Volume (2015-2020)
3.12.1 Rest of the World Active Pharmaceutical Ingredient Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Active Pharmaceutical Ingredient Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Active Pharmaceutical Ingredient Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Active Pharmaceutical Ingredient Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Active Pharmaceutical Ingredient Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Active Pharmaceutical Ingredient Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Active Pharmaceutical Ingredient Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Active Pharmaceutical Ingredient Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Active Pharmaceutical Ingredient Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Active Pharmaceutical Ingredient Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Active Pharmaceutical Ingredient Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Active Pharmaceutical Ingredient Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Active Pharmaceutical Ingredient Sales Volume Market Share by Type (2015-2020)
14.2 Global Active Pharmaceutical Ingredient Sales Revenue Market Share by Type (2015-2020)
14.3 Global Active Pharmaceutical Ingredient Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Active Pharmaceutical Ingredient Consumption Volume by Application (2015-2020)
15.2 Global Active Pharmaceutical Ingredient Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Active Pharmaceutical Ingredient Business
16.1 Teva
16.1.1 Teva Company Profile
16.1.2 Teva Active Pharmaceutical Ingredient Product Specification
16.1.3 Teva Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Roche
16.2.1 Roche Company Profile
16.2.2 Roche Active Pharmaceutical Ingredient Product Specification
16.2.3 Roche Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Johnson & Johnson
16.3.1 Johnson & Johnson Company Profile
16.3.2 Johnson & Johnson Active Pharmaceutical Ingredient Product Specification
16.3.3 Johnson & Johnson Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Novartis
16.4.1 Novartis Company Profile
16.4.2 Novartis Active Pharmaceutical Ingredient Product Specification
16.4.3 Novartis Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Dr. Reddys Laboratories
16.5.1 Dr. Reddys Laboratories Company Profile
16.5.2 Dr. Reddys Laboratories Active Pharmaceutical Ingredient Product Specification
16.5.3 Dr. Reddys Laboratories Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Pfizer
16.6.1 Pfizer Company Profile
16.6.2 Pfizer Active Pharmaceutical Ingredient Product Specification
16.6.3 Pfizer Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Sun Pharmaceutical Industries
16.7.1 Sun Pharmaceutical Industries Company Profile
16.7.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Specification
16.7.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 North China Pharmaceutical Group
16.8.1 North China Pharmaceutical Group Company Profile
16.8.2 North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Specification
16.8.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Mylan
16.9.1 Mylan Company Profile
16.9.2 Mylan Active Pharmaceutical Ingredient Product Specification
16.9.3 Mylan Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Aurobindo pharma
16.10.1 Aurobindo pharma Company Profile
16.10.2 Aurobindo pharma Active Pharmaceutical Ingredient Product Specification
16.10.3 Aurobindo pharma Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Zhejiang Medicine
16.11.1 Zhejiang Medicine Company Profile
16.11.2 Zhejiang Medicine Active Pharmaceutical Ingredient Product Specification
16.11.3 Zhejiang Medicine Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Hisun Pharmacy
16.12.1 Hisun Pharmacy Company Profile
16.12.2 Hisun Pharmacy Active Pharmaceutical Ingredient Product Specification
16.12.3 Hisun Pharmacy Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Boehringer Ingelheim GmbH
16.13.1 Boehringer Ingelheim GmbH Company Profile
16.13.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Specification
16.13.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Shandong Xinhua Pharmaceutical
16.14.1 Shandong Xinhua Pharmaceutical Company Profile
16.14.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Specification
16.14.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Biocon
16.15.1 Biocon Company Profile
16.15.2 Biocon Active Pharmaceutical Ingredient Product Specification
16.15.3 Biocon Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 DSM
16.16.1 DSM Company Profile
16.16.2 DSM Active Pharmaceutical Ingredient Product Specification
16.16.3 DSM Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Bayer
16.17.1 Bayer Company Profile
16.17.2 Bayer Active Pharmaceutical Ingredient Product Specification
16.17.3 Bayer Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Cambrex
16.18.1 Cambrex Company Profile
16.18.2 Cambrex Active Pharmaceutical Ingredient Product Specification
16.18.3 Cambrex Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Johnson Matthey
16.19.1 Johnson Matthey Company Profile
16.19.2 Johnson Matthey Active Pharmaceutical Ingredient Product Specification
16.19.3 Johnson Matthey Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 BASF
16.20.1 BASF Company Profile
16.20.2 BASF Active Pharmaceutical Ingredient Product Specification
16.20.3 BASF Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.21 North East Pharmaceutical
16.21.1 North East Pharmaceutical Company Profile
16.21.2 North East Pharmaceutical Active Pharmaceutical Ingredient Product Specification
16.21.3 North East Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.22 Lonza group
16.22.1 Lonza group Company Profile
16.22.2 Lonza group Active Pharmaceutical Ingredient Product Specification
16.22.3 Lonza group Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.23 Lupin
16.23.1 Lupin Company Profile
16.23.2 Lupin Active Pharmaceutical Ingredient Product Specification
16.23.3 Lupin Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.24 Tian Yao
16.24.1 Tian Yao Company Profile
16.24.2 Tian Yao Active Pharmaceutical Ingredient Product Specification
16.24.3 Tian Yao Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.25 Shandong Lukang Pharmaceutical
16.25.1 Shandong Lukang Pharmaceutical Company Profile
16.25.2 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Product Specification
16.25.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.26 Cipla
16.26.1 Cipla Company Profile
16.26.2 Cipla Active Pharmaceutical Ingredient Product Specification
16.26.3 Cipla Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.27 Jiangsu?Hengrui Medicine
16.27.1 Jiangsu?Hengrui Medicine Company Profile
16.27.2 Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Product Specification
16.27.3 Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.28 Huahai Pharmaceutical
16.28.1 Huahai Pharmaceutical Company Profile
16.28.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Specification
16.28.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.29 Albemarle
16.29.1 Albemarle Company Profile
16.29.2 Albemarle Active Pharmaceutical Ingredient Product Specification
16.29.3 Albemarle Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.30 Haerbin Pharmaceutical Group
16.30.1 Haerbin Pharmaceutical Group Company Profile
16.30.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Specification
16.30.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Active Pharmaceutical Ingredient Manufacturing Cost Analysis
17.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient
17.4 Active Pharmaceutical Ingredient Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Active Pharmaceutical Ingredient Distributors List
18.3 Active Pharmaceutical Ingredient Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Active Pharmaceutical Ingredient (2021-2026)
20.2 Global Forecasted Revenue of Active Pharmaceutical Ingredient (2021-2026)
20.3 Global Forecasted Price of Active Pharmaceutical Ingredient (2015-2026)
20.4 Global Forecasted Production of Active Pharmaceutical Ingredient by Region (2021-2026)
20.4.1 North America Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.3 Europe Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.7 Africa Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.9 South America Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Active Pharmaceutical Ingredient Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Active Pharmaceutical Ingredient by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.2 East Asia Market Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredient by Countriy
21.4 South Asia Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.5 Southeast Asia Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.6 Middle East Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.7 Africa Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.8 Oceania Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.9 South America Forecasted Consumption of Active Pharmaceutical Ingredient by Country
21.10 Rest of the world Forecasted Consumption of Active Pharmaceutical Ingredient by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer